190 related articles for article (PubMed ID: 17683614)
1. Portraits of breast cancer progression.
Dalgin GS; Alexe G; Scanfeld D; Tamayo P; Mesirov JP; Ganesan S; DeLisi C; Bhanot G
BMC Bioinformatics; 2007 Aug; 8():291. PubMed ID: 17683614
[TBL] [Abstract][Full Text] [Related]
2. Analysis of breast cancer progression using principal component analysis and clustering.
Alexe G; Dalgin GS; Ganesan S; Delisi C; Bhanot G
J Biosci; 2007 Aug; 32(5):1027-39. PubMed ID: 17914245
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer stratification from analysis of micro-array data of micro-dissected specimens.
Alexe G; Dalgin GS; Scanfeld D; Tamayo P; Mesirov JP; Ganesan S; Delisi C; Bhanot G
Genome Inform; 2007; 18():130-40. PubMed ID: 18546481
[TBL] [Abstract][Full Text] [Related]
4. Exploratory consensus of hierarchical clusterings for melanoma and breast cancer.
Mahata P
IEEE/ACM Trans Comput Biol Bioinform; 2010; 7(1):138-52. PubMed ID: 20150676
[TBL] [Abstract][Full Text] [Related]
5. Cancer molecular pattern discovery by subspace consensus kernel classification.
Han X
Comput Syst Bioinformatics Conf; 2007; 6():55-65. PubMed ID: 17951812
[TBL] [Abstract][Full Text] [Related]
6. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
Sharma M; Beck AH; Webster JA; Espinosa I; Montgomery K; Varma S; van de Rijn M; Jensen KC; West RB
Breast Cancer Res Treat; 2010 Sep; 123(2):397-404. PubMed ID: 19949854
[TBL] [Abstract][Full Text] [Related]
7. Kernel-imbedded Gaussian processes for disease classification using microarray gene expression data.
Zhao X; Cheung LW
BMC Bioinformatics; 2007 Feb; 8():67. PubMed ID: 17328811
[TBL] [Abstract][Full Text] [Related]
8. Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.
Moelans CB; de Weger RA; Monsuur HN; Maes AH; van Diest PJ
Anal Cell Pathol (Amst); 2010; 33(3):165-73. PubMed ID: 20978320
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.
Smith DD; Saetrom P; Snøve O; Lundberg C; Rivas GE; Glackin C; Larson GP
BMC Bioinformatics; 2008 Jan; 9():63. PubMed ID: 18226260
[TBL] [Abstract][Full Text] [Related]
10. Response projected clustering for direct association with physiological and clinical response data.
Yi SG; Park T; Lee JK
BMC Bioinformatics; 2008 Jan; 9():76. PubMed ID: 18237428
[TBL] [Abstract][Full Text] [Related]
11. Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.
Aure MR; Vitelli V; Jernström S; Kumar S; Krohn M; Due EU; Haukaas TH; Leivonen SK; Vollan HK; Lüders T; Rødland E; Vaske CJ; Zhao W; Møller EK; Nord S; Giskeødegård GF; Bathen TF; Caldas C; Tramm T; Alsner J; Overgaard J; Geisler J; Bukholm IR; Naume B; Schlichting E; Sauer T; Mills GB; Kåresen R; Mælandsmo GM; Lingjærde OC; Frigessi A; Kristensen VN; Børresen-Dale AL; Sahlberg KK;
Breast Cancer Res; 2017 Mar; 19(1):44. PubMed ID: 28356166
[TBL] [Abstract][Full Text] [Related]
12. Toward a measure of classification complexity in gene expression signatures.
Kamath V; Yeatman TJ; Eschrich SA
Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():5704-7. PubMed ID: 19164012
[TBL] [Abstract][Full Text] [Related]
13. Ensemble dependence model for classification and prediction of cancer and normal gene expression data.
Qiu P; Wang ZJ; Liu KJ
Bioinformatics; 2005 Jul; 21(14):3114-21. PubMed ID: 15879455
[TBL] [Abstract][Full Text] [Related]
14. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
15. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.
Park SY; Lee HE; Li H; Shipitsin M; Gelman R; Polyak K
Clin Cancer Res; 2010 Feb; 16(3):876-87. PubMed ID: 20103682
[TBL] [Abstract][Full Text] [Related]
17. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
[TBL] [Abstract][Full Text] [Related]
18. Differences and Relationships Between Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma Tissues in the Breast Based on Raman Spectroscopy.
Han B; Du Y; Fu T; Fan Z; Xu S; Hu C; Bi L; Gao T; Zhang H; Xu W
Appl Spectrosc; 2017 Feb; 71(2):300-307. PubMed ID: 28181469
[TBL] [Abstract][Full Text] [Related]
19. HER2 as a prognostic factor in breast cancer.
Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A
Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790
[TBL] [Abstract][Full Text] [Related]
20. Matriptase and survivin expression associated with tumor progression and malignant potential in breast cancer of Chinese women: tissue microarray analysis of immunostaining scores with clinicopathological parameters.
Tsai WC; Chu CH; Yu CP; Sheu LF; Chen A; Chiang H; Jin JS
Dis Markers; 2008; 24(2):89-99. PubMed ID: 18219094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
